Covid-19 Information for Health Professionals

 

Patient information on COVID-19

Link

NCCP Covid-19 Advice for People with Cancer Link

 

Systemic Anti-Cancer Therapy

 

Notice re NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the coronavirus (COVID-19) pandemic.

As of 23/05/2023, the guidance document ‘NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the coronavirus (COVID-19) pandemic’ has been retired. Healthcare professionals in all settings are advised to follow the COVID-19 guidance available via the HPSC, HSE and Department of Health websites.

As per HSE AMRIC guidance for implementation from 19/04/2023, the requirement for universal use of facemasks by healthcare workers, patients and visitors in healthcare settings has been removed, outside of periods of high levels of community transmission of COVID-19.

Guidance should be interpreted and applied locally in a context-specific manner, guided by a risk assessment approach, to include consideration of the local epidemiological situation with regard to COVID-19. Guidance is not a substitute for clinical judgement. As such, application of the guidance, and associated infection prevention and control measures, may vary between healthcare settings.

COVID- 19 guidance and advice is available from:

Further information may be found here:

  • General healthcare information: HSE Acute Hospital Infection Prevention and Control Precautions for Possible or Confirmed COVID-19 in a Pandemic Setting Guidance - available here
  • Vaccination information - available here
  • Testing information - available here
  • Treatment information - available here
 

 

Updated: 31/05/2023